Please Wait

Applying Filters...

Molecular glue degraders: Lilly, AbbVie sign billion-dollar deals; BMS leads with three late-stage drugs

Data Compilation
#PharmaFlow

Pipeline Prospector Feb 2025: Bain buys Mitsubishi Tanabe for US$ 3.4 bn; Japan’s Ono gets FDA nod for rare joint tumor drug

Stock Recap
#PipelineProspector

Ammonium Lactate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

7 API Suppliers, 5 USDMF, 4 Listed Suppliers, $ API Reference Price

FINISHED DOSAGE FORMULATIONS

9 FDF Dossiers, 8 FDA Orange Book, 1 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

LOTION;TOPICAL - EQ 12% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CREAM;TOPICAL - EQ 12% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Rochem International Inc, 2 DKSH, 2 Nanjing Well Pharmaceutical, 4 Actylis, 1 Aeon Procare, 6 BASF, 2 Corel Pharma Chem, 1 Finar, 4 Gangwal Chemicals, 6 Kerry, 2 Lubrizol Life Science Health, 3 Microlex e.U, 1 Nanjing Bold Chemical, 1 Pluviaendo, 4 Roquette, 7 Seppic, 1 Sigachi Industries, 1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

18 Topical, 14 Solubilizers, 10 Film Formers & Plasticizers, 10 Parenteral, 8 Thickeners and Stabilizers, 7 Coating Systems & Additives, 6 Co-Processed Excipients, 5 Emulsifying Agents, 4 Fillers, Diluents & Binders, 4 Lubricants & Glidants, 3 Surfactant & Foaming Agents, 2 API Stability Enhancers, 2 Direct Compression, 1 Disintegrants & Superdisintegrants, 1 Granulation, 1 Taste Masking, 1 Rheology Modifiers, 1 Controlled & Modified Release, 1 Chewable & Orodispersible Aids

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 4 Regulatory FDF Prices

MARKET PLACE

1 APIs

1 APIs

$ Xls download

Filters

Log in to access your PharmaMiles and download the data

Last Updated on PharmaCompass	Virtual Booth	Country	Holder	DMF No.	Subject	Submission Date	Status	Type	GDUFA DMF Review	GDUFA Review Date	GDUFA Payment Date
28/03/2025	Seqens	France	WAVELENGTH ENTERPRISES LTD	12003	AMMONIUM LACTATE	1996-06-17	Active	II	Complete	2023-11-02	2023-10-30
28/03/2025	Pfanstiehl	U.S.A	PFANSTIEHL INC	12612	AMMONIUM LACTATE	1997-08-05	Active	II	N/A

Contact us
to update this info

Ammonium Lactate

Ammonium Lactate

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

7 API Suppliers

5 USDMF

4 Listed Suppliers

$ API Reference Price

FINISHED DOSAGE FORMULATIONS

9 FDF Dossiers

8 FDA Orange Book

1 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

LOTION;TOPICAL - EQ 12% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CREAM;TOPICAL - EQ 12% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI

1 Rochem International Inc

2 DKSH

2 Nanjing Well Pharmaceutical

4 Actylis

1 Aeon Procare

6 BASF

2 Corel Pharma Chem

1 Finar

4 Gangwal Chemicals

6 Kerry

2 Lubrizol Life Science Health

3 Microlex e.U

1 Nanjing Bold Chemical

1 Pluviaendo

4 Roquette

7 Seppic

1 Sigachi Industries

1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

18 Topical

14 Solubilizers

10 Film Formers & Plasticizers

10 Parenteral

8 Thickeners and Stabilizers

7 Coating Systems & Additives

6 Co-Processed Excipients

5 Emulsifying Agents

4 Fillers, Diluents & Binders

4 Lubricants & Glidants

3 Surfactant & Foaming Agents

2 API Stability Enhancers

2 Direct Compression

1 Disintegrants & Superdisintegrants

1 Granulation

1 Taste Masking

1 Rheology Modifiers

1 Controlled & Modified Release

1 Chewable & Orodispersible Aids

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions

4 Regulatory FDF Prices

MARKET PLACE

1 APIs

Filters

LOTION;TOPICAL - EQ 12% BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CREAM;TOPICAL - EQ 12% BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons